Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04525534 · ClinicalTrials.gov registry record
Plasma Concentration of Biological Markers in Placenta Accreta Spectrum
A clinical trial, sponsored by University of Arkansas.
- Terminated
- Registry status
- 19
- Enrollment target
NCT04525534 is a clinical trial that was terminated before completion, run by University of Arkansas. The registered enrollment target is 19 participants.
The verdict
NCT04525534 was terminated before completion, sponsored by University of Arkansas.
- TERMINATED
- Registry status
- 19 participants
- Enrollment target
Study Summary
The purpose of this exploratory study is to determine how well maternal serum biomarkers and placental micro-particles (MP) correlate with placenta accreta spectrum (PAS) at the time of cesarean delivery in women with suspected PAS compared to women without PAS. Our aim is to determine if women with PAS have a unique MP and protein signature at the time of delivery compared with women without PAS.
Interventions
- OTHER There is no other intervention, only clinical treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2020-08-30 |
| Est. Completion | 2023-07-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04525534
The ClinicalTrials.gov registry entry for NCT04525534 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which There is no other intervention, only clinical treatment. is the first listed.
NCT04525534 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04525534 about?
NCT04525534 is a clinical study titled "Plasma Concentration of Biological Markers in Placenta Accreta Spectrum". The purpose of this exploratory study is to determine how well maternal serum biomarkers and placental micro-particles (MP) correlate with placenta accreta spectrum (PAS) at the time of cesarean delivery in women with suspected PAS compared to women without PAS. Our aim is to determine if women with...
What is the current status of trial NCT04525534?
This trial is currently terminated. The enrollment target is 19 participants. The study started on 2020-08-30. Estimated completion is 2023-07-10.
What interventions are being tested in trial NCT04525534?
The interventions under investigation include: There is no other intervention, only clinical treatment. (OTHER).
Who is sponsoring clinical trial NCT04525534?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.